We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+29.29%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$9.47B
AUM Growth
+$451M
Cap. Flow
+$1.13B
Cap. Flow %
11.96%
Top 10 Hldgs %
21.59%
Holding
903
New
107
Increased
255
Reduced
393
Closed
103

Top Buys

Rank Stock Value
1
BPMC
Blueprint Medicines
BPMC
+$51.9M
2
MRK icon
Merck
MRK
+$50.9M
3
DHR icon
Danaher
DHR
+$45.3M
4
TMO icon
Thermo Fisher Scientific
TMO
+$37.8M
5
JD icon
JD.com
JD
+$37.7M

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$103M
2
BABA icon
Alibaba
BABA
+$98.6M
3
CRM icon
Salesforce
CRM
+$62.5M
4
BMY icon
Bristol-Myers Squibb
BMY
+$59.4M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$48.6M

Sector Composition

Rank Sector Weight
1 Healthcare 34.61%
2 Technology 20.94%
3 Consumer Discretionary 8.9%
4 Financials 8.59%
5 Communication Services 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GAP
726
The Gap Inc
GAP
$7.3B
$202K ﹤0.01%
+15,989
New +$144K
BWA icon
727
BorgWarner
BWA
$12.9B
$200K ﹤0.01%
6,448
-110,797
-95% -$2.92M
CCJ icon
728
Cameco
CCJ
$37.9B
$200K ﹤0.01%
+19,546
New +$195K
KIM icon
729
Kimco Realty
KIM
$17.9B
$193K ﹤0.01%
15,029
-49,762
-77% -$554K
M icon
730
Macy's
M
$6.62B
$172K ﹤0.01%
25,000
-29,096
-54% -$179K
AAL icon
731
American Airlines Group
AAL
$10.2B
$170K ﹤0.01%
13,000
-38,752
-75% -$470K
CIG icon
732
CEMIG Preferred Shares
CIG
$6.21B
$145K ﹤0.01%
138,470
-9,691
-7% -$9.21K
ARAY icon
733
Accuray
ARAY
$29.9M
$142K ﹤0.01%
70,000
– –
QCLS
734
Q/C Technologies Inc
QCLS
$23.3M
$126K ﹤0.01%
6
+3
+100% +$65K
CHMA
735
DELISTED
Chiasma, Inc. Common Stock
CHMA
$126K ﹤0.01%
23,500
– –
GT icon
736
Goodyear
GT
$2.11B
$117K ﹤0.01%
+13,031
New +$99K
VALE icon
737
Vale
VALE
$62.9B
$110K ﹤0.01%
10,710
-32,450
-75% -$297K
ASUR icon
738
Asure Software
ASUR
$236M
$103K ﹤0.01%
+16,000
New +$99.8K
SKT icon
739
Tanger
SKT
$4.85B
$100K ﹤0.01%
+14,000
New +$92.6K
AUY
740
DELISTED
Yamana Gold, Inc.
AUY
$95K ﹤0.01%
+17,590
New +$84.1K
UMC icon
741
United Microelectronic
UMC
$43.8B
$94K ﹤0.01%
35,501
-17,224
-33% -$43.3K
SIRI icon
742
SiriusXM
SIRI
$10.5B
$92K ﹤0.01%
1,575
-7,896
-83% -$442K
CVE icon
743
Cenovus Energy
CVE
$51.3B
$86K ﹤0.01%
18,527
-10,294
-36% -$39.6K
ASX icon
744
ASE Group
ASX
$74.4B
$82K ﹤0.01%
18,156
-8,809
-33% -$37.6K
BSBR icon
745
Santander
BSBR
$41.4B
$62K ﹤0.01%
+12,444
New +$60.1K
FBIO icon
746
Fortress Biotech
FBIO
$110M
$60K ﹤0.01%
1,500
– –
ABEV icon
747
Ambev
ABEV
$48.7B
$40K ﹤0.01%
15,200
-414,170
-96% -$977K
TEL icon
748
TE Connectivity
TEL
$61.8B
$5K ﹤0.01%
61
+14
+30% +$1.05K
TM icon
749
Toyota
TM
$220B
$5K ﹤0.01%
40
+9
+29% +$1.12K
TMUSR
750
DELISTED
T-Mobile US, Inc. Subscription Rights Expiring 7/27/2020
TMUSR
$5K ﹤0.01%
+29,258
New +$8.22K
28 29
30
31 32

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q2 2020 Portfolio in Review

As of Q2 2020, Candriam SCA held 903 positions worth $9.47B, up 5% from $9.02B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA deployed $1.13B of net new capital in Q2 2020, opening 107 new positions and adding to 255 existing holdings. Its largest new stake was JD.com: 744,410 shares worth $44.8M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 31% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $103M trimmed.

  • Candriam SCA's largest Q2 2020 buy was JD.com: 744,410 shares worth $44.8M.
  • Candriam SCA added most to Blueprint Medicines in Q2 2020, an estimated $51.9M increase.
  • Candriam SCA's biggest Q2 2020 reduction was Regeneron Pharmaceuticals, cutting an estimated $103M.
  • Candriam SCA fully exited Salesforce in Q2 2020, selling an estimated $62.5M.
  • Candriam SCA's ten largest holdings make up 22% of its $9.47B portfolio in Q2 2020.
  • Candriam SCA opened 107 new positions and closed 103 in Q2 2020.
  • Candriam SCA's portfolio value rose 5% quarter-over-quarter to $9.47B.

Based on Candriam SCA's 13F filing for Q2 2020, filed 23 Jul 2020.